
The C-terminal α-MSH tripeptide studied for anti-inflammatory pathway research.
Secure checkout · Free AU express over $99 · Research use only
KPV (lysine-proline-valine) is the C-terminal tripeptide of alpha-melanocyte-stimulating hormone. It is studied in research for its modulation of inflammatory signalling, including NF-κB and pro-inflammatory cytokine pathways, in experimental models.
In controlled laboratory environments, KPV is studied for:
A synthetic Thymosin β4 fragment studied for actin regulation and repair research.
An investigational triple GIP/GLP-1/glucagon receptor agonist for metabolic research.
Join the Pepreta research list for new product drops, third-party COA releases and members-only pricing. No spam — unsubscribe anytime.